The Massachusetts attorney general’s office on Thursday made public a full copy of its lawsuit against Purdue Pharma, which it accuses of igniting the opioid epidemic through the deceptive marketing of its painkillers, including OxyContin.
The court filing details how the company considered expanding into addiction treatment, how much the Sackler family that controls Purdue and company executives were paid, and how the company was advised by McKinsey & Co. to improve its image in the face of concerns about addiction and overdoses.
STAT and ProPublica on Wednesday reported most of the still-secret contents of the suit, which were officially sealed until Thursday afternoon, at Purdue’s request.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect